Search Results - "Rogliani, P."

Pharmacology and Therapeutics of Bronchodilators Revisited by Matera, M G, Page, C P, Calzetta, L, Rogliani, P, Cazzola, M

“…Bronchodilators remain the cornerstone of the treatment of airway disorders such as asthma and chronic obstructive pulmonary disease (COPD). There is therefore…”
Get full text

Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles by Caminati, Marco, Vatrella, A, Rogliani, P, Carpagnano, E, Spanevello, A, Senna, G

“…An increasing amount of evidence supports the relevance of epithelium across the wide spectrum of asthma pathobiology. On a clinical ground tezepelumab,…”
Get full text

Asthma and comorbid medical illness by CAZZOLA, M, CALZETTA, L, BETTONCELLI, G, NOVELLI, L, CRICELLI, C, ROGLIANI, P

“…Asthma is associated with several comorbidities but the magnitude of the association has not been clearly defined. We aimed to examine the relationship between…”
Get full text

The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review by Calzetta, Luigino, Coppola, Angelo, Ritondo, Beatrice Ludovica, Matino, Matteo, Chetta, Alfredo, Rogliani, Paola

“…Long-acting muscarinic receptor antagonists (LAMAs) are the cornerstone for the treatment of chronic obstructive pulmonary disease (COPD); furthermore,…”
Get full text

Beyond Dual Bronchodilation - Triple Therapy, When and Why by Cazzola, Mario, Rogliani, Paola, Laitano, Rossella, Calzetta, Luigino, Matera, Maria Gabriella

“…Although pharmacological treatment of COPD is codified in different guidelines and strategy documents, there is abundant evidence of discrepancy between what…”
Get full text

Airflow obstruction: is it asthma or is it COPD? by Rogliani, Paola, Ora, Josuel, Puxeddu, Ermanno, Cazzola, Mario

“…Despite the availability of guideline recommendations, diagnostic confusion between COPD and asthma appears common, and often it is very difficult to decide…”
Get full text

Pharmacological treatments in asthma‐affected horses: A pair‐wise and network meta‐analysis by Calzetta, L., Roncada, P., Cave, D., Bonizzi, L., Urbani, A., Pistocchini, E., Rogliani, P., Matera, M. G.

“…Summary Background Equine asthma is a disease characterised by reversible airflow obstruction, bronchial hyper‐responsiveness and airway inflammation following…”
Get full text

Why is pet (cat/dog) allergen immunotherapy (AIT) such a controversial topic? Current perspectives and future directions by Liccardi, G, Martini, M, Bilò, M B, Cecchi, L, Milanese, M, Brussino, L, Motta, E, Rogliani, P

“…Dogs and cats are the most common pets worldwide. In Italy, the prevalence of allergic sensitization to cats and dogs is 16% and 9% respectively. The limited…”
Get full text

Intracellular Processing of Endothelial Nitric Oxide Synthase Isoforms Associated with Differences in Severity of Cardiopulmonary Diseases: Cleavage of Proteins with Aspartate vs. Glutamate at Position 298 by Tesauro, M, Thompson, W C, Rogliani, P, Qi, L, Chaudhary, P P, Moss, J

“…An endothelial nitric oxide synthase (eNOS) polymorphism in exon 7 (894 G/T) resulting in glutamate or aspartate, respectively, at position 298 on the protein…”
Get full text

Bronchospasm and iodinated contrast media (ICM): an accurate evaluation is mandatory by Liccardi, G, Martini, M, Bilò, M B, Milanese, M, Liccardi, M V, Pane, G, Zeccolini, R, Rogliani, P

Get full text

Clinical effect of corticosteroids in asthma‐affected horses: A quantitative synthesis by Calzetta, L., Rogliani, P., Page, C., Roncada, P., Pistocchini, E., Soggiu, A., Piras, C., Urbani, A., Matera, M.G.

“…Summary Background There are limited findings from low‐powered studies based on few number of subjects with equine asthma. Furthermore, no studies have been…”
Get full text

What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis by Lavorini, F., Bianco, A., Blasi, F., Braido, F., Corsico, A.G., Di Marco, F., Gentile, A., Paggiaro, P.L., Pegoraro, V., Pelaia, G., Rogliani, P., Santus, P., Scichilone, N., Soldi, A., Canonica, G.W.

“…The choice of inhaler device for asthma patients depends upon multiple attributes. We investigated factors that may drive general practitioners (GPs) and…”
Get full text

LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review by Rogliani, Paola, Calzetta, Luigino, Braido, Fulvio, Cazzola, Mario, Clini, Enrico, Pelaia, Girolamo, Rossi, Andrea, Scichilone, Nicola, Di Marco, Fabiano

“…The aim of this study was to assess the current evidence for long-acting β -agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-dose combinations…”
Get full text

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset [Corrigendum] by Calverley, Peter MA, Papi, Alberto, Page, Clive, Rogliani, Paola, Dal Negro, Roberto W, Cazzola, Mario, Cicero, Arrigo F, Wedzicha, Jadwiga A

“…Calverley PMA, Papi A, Page C, et al. 2022;17:1909-1920. The authors wish to correct Figure 1 on page 1912 after it came to their attention an error had been…”
Get full text

Acute exacerbations of COPD: risk factors for failure and relapse by Mantero, Marco, Rogliani, Paola, Di Pasquale, Marta, Polverino, Eva, Crisafulli, Ernesto, Guerrero, Monica, Gramegna, Andrea, Cazzola, Mario, Blasi, Francesco

“…Acute exacerbations are a leading cause of worsening COPD in terms of lung function decline, quality of life, and survival. They also have a relevant economic…”
Get full text

The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis by Rogliani, Paola, Matera, Maria Gabriella, Ora, Josuel, Cazzola, Mario, Calzetta, Luigino

“…Long-acting β -agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) are burdened by the potential risk of inducing cardiovascular serious adverse…”
Get full text

Severe asthma and long-term Benralizumab effectiveness in real-life by Sposato, B, Scalese, M, Camiciottoli, G, Carpagnano, G E, Pelaia, C, Santus, P, Pelaia, G, Palmiero, G, Di Tomassi, M, Ronchi, M C, Cameli, P, Bargagli, E, Ciambellotti, L, Rizzello, S, Sglavo, R, Coppola, A, Lacerenza, L G, Gabriele, M, Radovanovic, D, Perrella, A, Ricci, A, Rogliani, P

“…Long-term efficacy of Benralizumab in real life is not clearly known. We assessed the long-term effectiveness persistence to anti-IL-5R treatment in a group of…”
Get more information

COVID-19 lockdown, personal protective equipment, hyper-hygiene and allergy by Liccardi, G, Bilò, M B, Milanese, M, Martini, M, Pane, G, De Maio, A, Rogliani, P

“…At the beginning of SARS-CoV 2 pandemic, in the absence of "targeted" therapies, the national health authorities have introduced some measures aimed at…”
Get full text

Day and Night Control of COPD and Role of Pharmacotherapy: A Review by Braghiroli, Alberto, Braido, Fulvio, Piraino, Alessio, Rogliani, Paola, Santus, Pierachille, Scichilone, Nicola

“…The topic of 24-hour management of COPD is related to day-to-night symptoms management, specific follow-up and patients' adherence to therapy. COPD symptoms…”
Get full text

Combining long‐acting bronchodilators with different mechanisms of action: A pharmacological approach to optimize bronchodilation of equine airways by Calzetta, L., Rogliani, P., Pistocchini, E., Mattei, M., Cito, G., Alfonsi, P., Page, C., Matera, M. G.

“…The ultra long‐acting β2‐adrenoceptor agonist olodaterol plus the ultra long‐acting muscarinic antagonist tiotropium bromide are known to relax equine airways…”
Get full text